You are here: All Products  > Antengene Doses First Patient in Trial of ERK1/2 Inhibitor Combined with BMS’s PD-1

Antengene Doses First Patient in Trial of ERK1/2 Inhibitor Combined with BMS’s PD-1

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products